Published • loading... • Updated
CVS Unit Omnicare Wins Court Approval for $250 Million Sale to GenieRx
The court approved the transaction after Omnicare completed a comprehensive sale process, with GenieRx backed by Milrose Capital and Integro Asset Management.
- On Wednesday, the U.S. Bankruptcy Court for the Northern District of Texas approved the sale of Omnicare, a CVS Health subsidiary, to GenieRx Holdings LLC in a deal valued at about $250 million.
- The court approval followed a comprehensive sale process aimed at restructuring the pharmacy business, which serves long-term care facilities and assisted living communities across the United States.
- GenieRx is a joint partnership between private investment firm Milrose Capital LLC and healthcare investment firm Integro Asset Management LLC, which operates as Integro Healthcare Services.
- Integro Healthcare Services CEO David Pazzolina stated the partnership intends to strengthen Omnicare's operations while maintaining commitment to clinical excellence and customer support.
- The transaction is expected to close later this year, subject to regulatory approvals and customary closing conditions, as Omnicare continues serving residents.
Insights by Ground AI
18 Articles
18 Articles
Mason City Globe Gazette+15 Reposted by 15 other sources
Omnicare Receives Court Approval for Sale of Business to GenieRx
WOONSOCKET, R.I., May 13, 2026 /PRNewswire/ -- Omnicare, LLC (the "Company" or "Omnicare"), a subsidiary of CVS Health (NYSE: CVS), today announced that following a comprehensive sale process, the U.S. Bankruptcy Court for the Northern District of Texas (the "Court")…
Coverage Details
Total News Sources18
Leaning Left0Leaning Right1Center10Last UpdatedBias Distribution91% Center
Bias Distribution
- 91% of the sources are Center
91% Center
C 91%
Factuality
To view factuality data please Upgrade to Premium
